Camlin Fine
Camlin Fine Q1 FY26 earnings call: Revenue & Margins
Q1 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
The Blends business is expected to grow at least 15% annually in all geographies, with some regions growing faster. - Revenue projections for key regions: - Mexico (Central America): $50M+ in current year, targeting 20%+ EBITDA margin. - North America: $30-35M this year with 10-12% EBITDA margin; projected $50M+ next year with high-teen margins. - Brazil: $25-28M current year with ~10% margin; projected $35-40M next year with mid-teens margin. - CFS Vitafor: $15-16M current year with 5-10% margin; targeting $25M+ next year with margins above 10%. - Vanillin sales expected at 2,500-3,000 tons, with U.S. Vanillin Business: Expected volume of 2,500 to 3,000 tons annually with realizations of $13-$14 per kg on average; full capacity utilization anticipated by FY '28 with 70-80% utilization by FY '27, indicating growth potential in earnings. - Blends Business: Targeting growth across geographies at least 15%, some more, with EBITDA margins ranging from low double digits to high teens; Mexico shows ~17%+ EBITDA margins, North America aiming for mid-teens margin. - EBITDA Guidance: No specific numeric guidance, but sustained margins expected barring one-offs; sustainable gross margin estimated at 40-45% (±2-3%), slightly below recent one-off driven 50%+. - Cost Controls: Investment in sales/technical teams especially in the U.S.
From Camlin Fine's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- The Blends business is expected to grow at least 15% annually in all geographies, with some regions growing faster.
- Revenue projections for key regions:
- Mexico (Central America): $50M+ in current year, targeting 20%+ EBITDA margin.
- North America: $30-35M this year with 10-12% EBITDA margin; projected $50M+ next year with high-teen margins.
- Brazil: $25-28M current year with ~10% margin; projected $35-40M next year with mid-teens margin.
- CFS Vitafor: $15-16M current year with 5-10% margin; targeting $25M+ next year with margins above 10%.
- Vanillin sales expected at 2,500-3,000 tons, with U.S. and Europe contributing 1,800-2,000 tons combined; rest of world 600-800 tons.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Camlin Fine said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Camlin Fine said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Vanillin orders for the U.S. and Europe are typically finalized around October-November for deliveries starting January.
- Current inventory (channel stock) in U.S. and Europe is estimated at 1,800 to 2,000 tons; 600 to 1,200 tons for the rest of the world.
- The inventory overhang in U.S. and Europe is expected to clear within 3 to 4 months from the time of discussion.
- Expected vanillin sales volume is around 2,500 to 3,000 tons annually, with 1,800 to 2,000 tons from U.S. and Europe combined.
- Vanillin production capacity utilization is around 50-60%, with 70-80% forecasted for FY '27 and full capacity by FY '28.
2 more points management made on order book & pipeline
Camlin Fine — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹425 Cr, net profit ₹86 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Camlin Fine's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Balaji Amines Ltd (Q1 FY26)
Q1FY26 consolidated revenue from operations: ₹367 crore, up 2% quarter-on-quarter from ₹361 crore in Q4FY25, but down 7% year-on-year from ₹393 crore in Q1FY25…
- Linde India Ltd (Q1 FY26)
Net Revenue for FY ended Mar’25 was INR 24,854 million, down 10.2% (–2,833 million) YoY from INR 27,687 million. Key concall takeaways from Linde India Ltd's…
- Vidhi Specialty Food Ingredients Ltd (Q1 FY26)
87.9 Crores . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.
- Chemcon Speciality Chemicals Ltd (Q1 FY26)
Q1 FY26 revenue from operations: ₹53.5 Cr, up 18% YoY from ₹45.5 Cr in Q1 FY25 (Page 7 & 6). Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q1…
Frequently Asked Questions
What were Camlin Fine Q1 FY26 results?
The Blends business is expected to grow at least 15% annually in all geographies, with some regions growing faster. - Revenue projections for key regions: - Mexico (Central America): $50M+ in current year, targeting 20%+ EBITDA margin. - North America: $30-35M this year with 10-12% EBITDA margin; projected $50M+ next year with high-teen margins. - Brazil: $25-28M current year with ~10% margin; projected $35-40M next year with mid-teens margin. - CFS Vitafor: $15-16M current year with 5-10% margin; targeting $25M+ next year with margins above 10%. - Vanillin sales expected at 2,500-3,000 tons, with U.S. Vanillin Business: Expected volume of 2,500 to 3,000 tons annually with realizations of $13-$14 per kg on average; full capacity utilization anticipated by FY '28 with 70-80% utilization by FY '27, indicating growth potential in earnings. - Blends Business: Targeting growth across geographies at least 15%, some more, with EBITDA margins ranging from low double digits to high teens; Mexico shows ~17%+ EBITDA margins, North America aiming for mid-teens margin. - EBITDA Guidance: No specific numeric guidance, but sustained margins expected barring one-offs; sustainable gross margin estimated at 40-45% (±2-3%), slightly below recent one-off driven 50%+. - Cost Controls: Investment in sales/technical teams especially in the U.S.
What is Camlin Fine share price analysis?
Camlin Fine currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹1,993 Cr. Investors should review the full earnings analysis for detailed insights.
Is Camlin Fine planning capital expenditure?
The transcript and document on page 16 do not explicitly mention any current or future capex, capital investment, or strategic investment plans by Camlin Fine Sciences Limited during the Q1 FY26 earnings call held on August 8, 2025.
Keep Camlin Fine on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.